RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA

Calimeri T, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Steffanoni S, Foppoli M, Celico C, Falautano M, Nonis A, La Rosee P, Binder M, Fabbri A, Ilariucci F, Krampera M, Roth A, Hemmaway C, Johnson PW, Linton KM, Pukrop T, Sonderskov Gorlov J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Zanni M, Krause S, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Thurner L, Cabras G, Pennese E, Ponzoni M, Deckert M, Politi LS, Finke J, Ferranti A, Cozens K, Burger E, Ielmini N, Cavalli F, Zucca E, Illerhaus G, Ferreri AJM (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: FERRATA STORTI FOUNDATION

City/Town: PAVIA

Pages Range: 33-33

Conference Proceedings Title: HAEMATOLOGICA

Authors with CRIS profile

Involved external institutions

Università Vita-Salute San Raffaele (UniSR) Italy (IT) King's College Hospital (KCH) United Kingdom (GB) Christie NHS Foundation Trust United Kingdom (GB) Universitätsklinikum Köln Germany (DE) Aintree University Hospital United Kingdom (GB) Universitätsklinikum Gießen und Marburg (UKGM) Germany (DE) Azienda Ospedaliera Nazionale SS.Antonio e Biagio e C.Arrigo Italy (IT) Universität Ulm Germany (DE) International Extranodal Lymphoma Study Group (IELSG) Switzerland (CH) Klinikum Stuttgart Germany (DE) Aarhus University Hospital / Aarhus Universitetshospital Denmark (DK) Arcispedale Santa Maria Nuova Italy (IT) Rigshospitalet Denmark (DK) Martin-Luther-Universität Halle-Wittenberg (MLU) Germany (DE) Oncology Institute of Southern Switzerland / Istituto Oncologico della Svizzera Italiana Switzerland (CH) Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino Italy (IT) Universitätsklinikum des Saarlandes (UKS) Germany (DE) University Hospital Southampton NHS United Kingdom (GB) Universitätsklinikum Freiburg Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) Germany (DE) Nottingham University Hospitals United Kingdom (GB) Queen's Hospital United Kingdom (GB) University of Verona / Università degli Studi di Verona Italy (IT) Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Italy (IT) Ospedale Civile Santo Spirito Italy (IT) Johannes Gutenberg-Universität Mainz (JGU) Germany (DE) Universitätsklinikum Jena Germany (DE) Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Germany (DE) Technische Universität München (TUM) Germany (DE) University Hospital Siena Italy (IT) Fondazione Italiana Linfomi Onlus, Foundation Italiana Linfomi Italy (IT) Georg-August-Universität Göttingen Germany (DE) Universitätsklinikum Essen Germany (DE) Istituto Clinico Humanitas Italy (IT) Klinikverbund Bremen (Gesundheit Nord) Germany (DE) Istituto Nazionale Tumori Regina Elena (IRE) Italy (IT)

How to cite

APA:

Calimeri, T., Cwynarski, K., Pulczynski, E., Fox, C.P., Schorb, E., Steffanoni, S.,... Ferreri, A.J.M. (2021). RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA. In HAEMATOLOGICA (pp. 33-33). PAVIA: FERRATA STORTI FOUNDATION.

MLA:

Calimeri, T., et al. "RESULTS OF THE IELSG32 TRIAL AT A MEDIAN FOLLOW-UP OF 88 MONTHS DEMONSTRATE THAT MATRIX FOLLOWED BY AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH EXCELLENT SURVIVAL AND NEUROTOLERABILITY IN PATIENTS WITH PRIMARY CNS LYMPHOMA." Proceedings of the HAEMATOLOGICA PAVIA: FERRATA STORTI FOUNDATION, 2021. 33-33.

BibTeX: Download